about
Recent progress in the pharmacotherapy of Churg-Strauss syndrome.The linkage between Churg-Strauss syndrome and leukotriene receptor antagonists: fact or fiction?Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma.Anti-neutrophil cytoplasmic antibody-associated systemic vasculitis: nature or nurture?Montelukast-induced generalized urticaria.
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Leukotriene antagonists and the Churg-Strauss syndrome.
@ast
Leukotriene antagonists and the Churg-Strauss syndrome.
@en
Leukotriene antagonists and the Churg-Strauss syndrome.
@nl
type
label
Leukotriene antagonists and the Churg-Strauss syndrome.
@ast
Leukotriene antagonists and the Churg-Strauss syndrome.
@en
Leukotriene antagonists and the Churg-Strauss syndrome.
@nl
prefLabel
Leukotriene antagonists and the Churg-Strauss syndrome.
@ast
Leukotriene antagonists and the Churg-Strauss syndrome.
@en
Leukotriene antagonists and the Churg-Strauss syndrome.
@nl
P2093
P356
P1476
Leukotriene antagonists and the Churg-Strauss syndrome
@en
P2093
Ayman Tawil
Ghassan Jamaleddine
Karim Diab
Zuhayr Tabbarah
P304
P356
10.1053/SARH.2002.27735
P577
2002-02-01T00:00:00Z